Healthcare and Life Science
CN Bio raises $21 million USD in first close of Series B investment round
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutions Cambridge, UK - CN Bio, a leadi...
Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance
First senior executive appointment made following Company launch to oversee strategic development of clinical programs ...
Navigating payer challenges in rare disease
Clinical and economic evidence generation across rare diseases is challenging due to intrinsic disease characteristics, misalignment on treatment costs, and inadequate traditional evaluation frameworks. Therefore, rare disease products face unique payer challenges, which need to be comp...
Sable&Hawkes deliver new website for Granta Veterinary Specialists
As part of a wider brand identity for our client Granta Veterinary Specialists – Sable&Hawkes, working with Pick Digital, have delivered a new corporate website. ...
Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes. ...
Guardtech Group strengthen sales team with addition of new GMP Commercial Manager
Cleanroom construction experts set to elevate full-package offering with recruitment of experienced Pharma specialist John Edwards ...
Improving adherence in Asthma treatment
Asthma, a common respiratory disorder affects more than 8 million people in the UK alone [1]. Despite the availability of effective treatments, inhaled corticosteroids (ICS) which are the mainstay of asthma treatment, often show limited efficacy because of suboptimal patient adherence. ...
Zyme Communications expands UK head office with new facilities at Cambridge Innovation Park
Investment in new headquarters forms part of ongoing company growth plans and supports Zyme’s continued success, following client base and team expansion. ...
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth. ...
ELRIG UK and SRG announce partnership to advance life science professionals in drug discovery
Partnership endorses mission to facilitate career progression and support life science industry growth. ...